Muscle and Heart Function Restoration in a Limb Girdle Muscular Dystrophy 2I (LGMD2I) Mouse Model by Systemic FKRP Gene Delivery

Emery, 2002, The muscular dystrophies, Lancet, 359, 687, 10.1016/S0140-6736(02)07815-7 Michele, 2002, Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies, Nature, 418, 417, 10.1038/nature00837 Godfrey, 2007, Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan, Brain, 130, 2725, 10.1093/brain/awm212 Mercuri, 2003, Phenotypic spectrum associated with mutations in the fukutin-related protein gene, Ann Neurol, 53, 537, 10.1002/ana.10559 Kuga, 2012, Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan, J Biol Chem, 287, 9560, 10.1074/jbc.M111.271767 Bowe, 1994, Identification and purification of an agrin receptor from Torpedo postsynaptic membranes: a heteromeric complex related to the dystroglycans, Neuron, 12, 1173, 10.1016/0896-6273(94)90324-7 Sugita, 2001, A stoichiometric complex of neurexins and dystroglycan in brain, J Cell Biol, 154, 435, 10.1083/jcb.200105003 Barresi, 2006, Dystroglycan: from biosynthesis to pathogenesis of human disease, J Cell Sci, 119, 199, 10.1242/jcs.02814 Brockington, 2010, Transgenic overexpression of LARGE induces α-dystroglycan hyperglycosylation in skeletal and cardiac muscle, PLoS One, 5, e14434, 10.1371/journal.pone.0014434 Longman, 2003, Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan, Hum Mol Genet, 12, 2853, 10.1093/hmg/ddg307 van Reeuwijk, 2005, POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome, J Med Genet, 42, 907, 10.1136/jmg.2005.031963 Beltran-Valero de Bernabe, 2002, Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome, Am J Human Genet, 71, 1033, 10.1086/342975 Yoshida, 2001, Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1, Dev Cell, 1, 717, 10.1016/S1534-5807(01)00070-3 Kobayashi, 1998, An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy, Nature, 394, 388, 10.1038/28256 Brockington, 2001, Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C, Hum Mol Genet, 10, 2851, 10.1093/hmg/10.25.2851 Manya, 2004, Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity, Proc Natl Acad Sci USA, 101, 500, 10.1073/pnas.0307228101 Yoshida-Moriguchi, 2010, O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding, Science, 327, 88, 10.1126/science.1180512 Brown, 2004, Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies, Am J Pathol, 164, 727, 10.1016/S0002-9440(10)63160-4 Hong, 2011, Asian patients with limb girdle muscular dystrophy 2I (LGMD2I), J Clin Neurosci, 18, 494, 10.1016/j.jocn.2010.08.010 Beltran-Valero de Bernabe, 2004, Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome, J Med Genet, 41, e61, 10.1136/jmg.2003.013870 Chan, 2010, Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies, Hum Mol Genet, 19, 3995, 10.1093/hmg/ddq314 Wang, 2011, Post-Natal knockdown of fukutin-related protein expression in muscle by long-termRNA interference induces dystrophic pathology [corrected], Am J Pathol, 178, 261, 10.1016/j.ajpath.2010.11.020 Xu, 2013, Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of α-dystroglycan and improves muscle functions, Mol Ther, 21, 1832, 10.1038/mt.2013.156 Xiao, 1996, Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector, J Virol, 70, 8098, 10.1128/JVI.70.11.8098-8108.1996 Wang, 2000, Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model, Proc Natl Acad Sci USA, 97, 13714, 10.1073/pnas.240335297 Harper, 2002, Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy, Nat Med, 8, 253, 10.1038/nm0302-253 Kornegay, 2010, Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs, Mol Ther, 18, 1501, 10.1038/mt.2010.94 Qiao, 2005, Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin, Proc Natl Acad Sci USA, 102, 11999, 10.1073/pnas.0502137102 Stedman, 1991, The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy, Nature, 352, 536, 10.1038/352536a0 Mokuno, 1987, Serum creatine kinase isoenzymes in Duchenne muscular dystrophy determined by sensitive enzyme immunoassay methods, Muscle Nerve, 10, 459, 10.1002/mus.880100513 Watchko, 2002, Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice, Hum Gene Ther, 13, 1451, 10.1089/10430340260185085 Wang, 2005, Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart, Nat Biotechnol, 23, 321, 10.1038/nbt1073 Sveen, 2008, Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy, Arch Neurol, 65, 1196, 10.1001/archneur.65.9.1196 Wang, 2008, Construction and analysis of compact muscle-specific promoters for AAV vectors, Gene Ther, 15, 1489, 10.1038/gt.2008.104 Li, 1999, Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences, Nat Biotechnol, 17, 241, 10.1038/6981 Wu, 2008, Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer, Proc Natl Acad Sci USA, 105, 14814, 10.1073/pnas.0805676105 Mertes, 1993, Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients, Circulation, 88, 15, 10.1161/01.CIR.88.1.15 He, 2012, Enhancing muscle membrane repair by gene delivery of MG53 ameliorates muscular dystrophy and heart failure in δ-Sarcoglycan-deficient hamsters, Mol Ther, 20, 727, 10.1038/mt.2012.5 Hollingsworth, 2013, Subepicardial dysfunction leads to global left ventricular systolic impairment in patients with limb girdle muscular dystrophy 2I, Eur J Heart Fail, 15, 986, 10.1093/eurjhf/hft057 Wahbi, 2008, Cardiac assessment of limb-girdle muscular dystrophy 2I patients: an echography, Holter ECG and magnetic resonance imaging study, Neuromuscul Disord, 18, 650, 10.1016/j.nmd.2008.06.365 Li, 1999, rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy, Gene Ther, 6, 74, 10.1038/sj.gt.3300830 Qiao, 2011, Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver, Gene Ther, 18, 403, 10.1038/gt.2010.157 Xiao, 1998, Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus, J Virol, 72, 2224, 10.1128/JVI.72.3.2224-2232.1998 Ayuso, 2010, High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency, Gene Ther, 17, 503, 10.1038/gt.2009.157 Rohr, 2005, Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles, J Virol Methods, 127, 40, 10.1016/j.jviromet.2005.03.006 Veldwijk, 2002, Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks, Mol Ther, 6, 272, 10.1006/mthe.2002.0659 Qiao, 2008, Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice, Hum Gene Ther, 19, 241, 10.1089/hum.2007.159 Xiao, 2000, Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy, J Virol, 74, 1436, 10.1128/JVI.74.3.1436-1442.2000 Bojak, 2002, Muscle specific versus ubiquitous expression of Gag based HIV-1 DNA vaccines: a comparative analysis, Vaccine, 20, 1975, 10.1016/S0264-410X(02)00081-6